Regent Peak Wealth Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1803329 ATLANTA, GA

Position in GILD

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$240,172

-$19,613 QoQ

Shares Held

1,901

+2.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,807

of 2,266 holders

Holding Since

Mar 2020

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Regent Peak Wealth Advisors LLC holds $8,685,911 across 6 Drug Manufacturers - General names. GILD ranks #6 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,995	$3,592,293
2	ABBV	AbbVie Inc.	6,538	$1,645,222
3	JNJ	Johnson & Johnson	6,475	$1,644,455
4	MRK	Merck & Co., Inc.	7,297	$937,664
5	AMGN	Amgen Inc	1,729	$626,105
6	GILD	Gilead Sciences, Inc. This page	1,901	$240,172

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$240,172	1,901	+2.0%	Shares	Sole	2026-07-10
2026-03-31	$259,785	1,864	+7.7%	Shares	Sole	2026-04-14
2025-12-31	$212,462	1,731	-35.0%	Shares	Sole	2026-01-08
2022-12-31	$228,532	2,662	+163.8%	Shares	Sole	2023-02-08
2020-12-31	$58,784	1,009	-78.8%	Shares	Sole	2021-02-12
2020-03-31	$355,035	4,749	—	Shares	Sole	2020-04-27
No filing history on record for this holder in this stock.